Report Detail
Global (United States, European Union and China) Circulating Tumor Cell Diagnostics Market Research Report 2019-2025
- RnM3702637 |
- 27 August, 2019 |
- Global |
- 125 Pages |
- QYResearch |
- Pharma & Healthcare
Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various tumor markers that can be used along with companion diagnostics to diagnose or monitor various forms of cancer are expected to boost usage rates of CTC tests in the coming years.
Circulating tumor cell detection test possesses the ability to detect, quantify, and analyze tumor cells in the blood of cancer patients. It includes enrichment, detection and analysis of the detected circulating tumor cells. Circulating tumor cells tests are applicable in the characterization of tumor cells through biochemical marker analysis. CTC isolation, detection, and molecular characterization systems find investigational application in prostate, breast, colon, head, neck, skin, lung, and pancreatic cancer
Growing incidences oncology diseases and the introduction of novel biotechnological methods that enable the isolation and quantitation of circulating tumor cells. Furthermore, other factors like early disease diagnosis, cost savings on multiple treatments, drug safety, patient compliance, and optimization of therapies are attributive for rising demand for the preventive medicine, thus influencing the demand for CTC tests.
On course of the forecast period it is expected that over 150 companion diagnostic on-label combinations and a range of personalized therapeutic drugs under clinical trials and development pipelines based on companion diagnostics. The level of adoption of companion diagnostics is expected to significantly increase after these obtain complete FDA approval and are commercialized fully.
In 2019, the market size of Circulating Tumor Cell Diagnostics is 4990 million US$ and it will reach 10100 million US$ in 2025, growing at a CAGR of 9.2% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Circulating Tumor Cell Diagnostics.
This report studies the global market size of Circulating Tumor Cell Diagnostics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Circulating Tumor Cell Diagnostics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Janssen Diagnostics
Advanced Cell Diagnostics
Aviva Biosciences
Biocept Inc
Biofluidica Inc.
CellTraffix Inc.
Clearbridge BioMedics Pte Ltd
Epic Sciences Inc.
Fluxion Biosciences Inc.
ScreenCell
Silicon Biosystems
Sysmex Corporation
Greiner Bio-One GmbH
AdnaGen AG
Apocell Inc
Biocep Ltd
Canopus Bioscience Ltd
Creatv Microtech Inc
Ikonisys Inc
IV Diagnostics Inc
Miltenyi Biotech GmbH
Nanostring Technologies Inc
Rarecells Diagnostics.
Vitatex Inc
Market Segment by Product Type
CTC Enrichment
CTC Detection
CTC Analysis
Market Segment by Application
Tumorigenesis research
EMT biomarkers development
Cancer stem cell research
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Circulating Tumor Cell Diagnostics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Circulating Tumor Cell Diagnostics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Circulating Tumor Cell Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Circulating Tumor Cell Diagnostics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 CTC Enrichment
- 1.3.3 CTC Detection
- 1.3.4 CTC Analysis
- 1.4 Market Segment by Application
- 1.4.1 Global Circulating Tumor Cell Diagnostics Market Share by Application (2019-2025)
- 1.4.2 Tumorigenesis research
- 1.4.3 EMT biomarkers development
- 1.4.4 Cancer stem cell research
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Circulating Tumor Cell Diagnostics Market Size
- 2.1.1 Global Circulating Tumor Cell Diagnostics Revenue 2014-2025
- 2.1.2 Global Circulating Tumor Cell Diagnostics Sales 2014-2025
- 2.2 Circulating Tumor Cell Diagnostics Growth Rate by Regions
- 2.2.1 Global Circulating Tumor Cell Diagnostics Sales by Regions 2014-2019
- 2.2.2 Global Circulating Tumor Cell Diagnostics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Circulating Tumor Cell Diagnostics Sales by Manufacturers
- 3.1.1 Circulating Tumor Cell Diagnostics Sales by Manufacturers 2014-2019
- 3.1.2 Circulating Tumor Cell Diagnostics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Circulating Tumor Cell Diagnostics Revenue by Manufacturers (2014-2019)
- 3.2.2 Circulating Tumor Cell Diagnostics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Circulating Tumor Cell Diagnostics Market Concentration Ratio (CR5 and HHI)
- 3.3 Circulating Tumor Cell Diagnostics Price by Manufacturers
- 3.4 Key Manufacturers Circulating Tumor Cell Diagnostics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Circulating Tumor Cell Diagnostics Market
- 3.6 Key Manufacturers Circulating Tumor Cell Diagnostics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 CTC Enrichment Sales and Revenue (2014-2019)
- 4.1.2 CTC Detection Sales and Revenue (2014-2019)
- 4.1.3 CTC Analysis Sales and Revenue (2014-2019)
- 4.2 Global Circulating Tumor Cell Diagnostics Sales Market Share by Type
- 4.3 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Type
- 4.4 Circulating Tumor Cell Diagnostics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Circulating Tumor Cell Diagnostics Sales by Application
6 United States
- 6.1 United States Circulating Tumor Cell Diagnostics Breakdown Data by Company
- 6.2 United States Circulating Tumor Cell Diagnostics Breakdown Data by Type
- 6.3 United States Circulating Tumor Cell Diagnostics Breakdown Data by Application
7 European Union
- 7.1 European Union Circulating Tumor Cell Diagnostics Breakdown Data by Company
- 7.2 European Union Circulating Tumor Cell Diagnostics Breakdown Data by Type
- 7.3 European Union Circulating Tumor Cell Diagnostics Breakdown Data by Application
8 China
- 8.1 China Circulating Tumor Cell Diagnostics Breakdown Data by Company
- 8.2 China Circulating Tumor Cell Diagnostics Breakdown Data by Type
- 8.3 China Circulating Tumor Cell Diagnostics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Circulating Tumor Cell Diagnostics Breakdown Data by Company
- 9.2 Rest of World Circulating Tumor Cell Diagnostics Breakdown Data by Type
- 9.3 Rest of World Circulating Tumor Cell Diagnostics Breakdown Data by Application
- 9.4 Rest of World Circulating Tumor Cell Diagnostics Breakdown Data by Countries
- 9.4.1 Rest of World Circulating Tumor Cell Diagnostics Sales by Countries
- 9.4.2 Rest of World Circulating Tumor Cell Diagnostics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Janssen Diagnostics
- 10.1.1 Janssen Diagnostics Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Circulating Tumor Cell Diagnostics
- 10.1.4 Circulating Tumor Cell Diagnostics Product Introduction
- 10.1.5 Janssen Diagnostics Recent Development
- 10.2 Advanced Cell Diagnostics
- 10.2.1 Advanced Cell Diagnostics Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Circulating Tumor Cell Diagnostics
- 10.2.4 Circulating Tumor Cell Diagnostics Product Introduction
- 10.2.5 Advanced Cell Diagnostics Recent Development
- 10.3 Aviva Biosciences
- 10.3.1 Aviva Biosciences Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Circulating Tumor Cell Diagnostics
- 10.3.4 Circulating Tumor Cell Diagnostics Product Introduction
- 10.3.5 Aviva Biosciences Recent Development
- 10.4 Biocept Inc
- 10.4.1 Biocept Inc Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Circulating Tumor Cell Diagnostics
- 10.4.4 Circulating Tumor Cell Diagnostics Product Introduction
- 10.4.5 Biocept Inc Recent Development
- 10.5 Biofluidica Inc.
- 10.5.1 Biofluidica Inc. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Circulating Tumor Cell Diagnostics
- 10.5.4 Circulating Tumor Cell Diagnostics Product Introduction
- 10.5.5 Biofluidica Inc. Recent Development
- 10.6 CellTraffix Inc.
- 10.6.1 CellTraffix Inc. Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Circulating Tumor Cell Diagnostics
- 10.6.4 Circulating Tumor Cell Diagnostics Product Introduction
- 10.6.5 CellTraffix Inc. Recent Development
- 10.7 Clearbridge BioMedics Pte Ltd
- 10.7.1 Clearbridge BioMedics Pte Ltd Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Circulating Tumor Cell Diagnostics
- 10.7.4 Circulating Tumor Cell Diagnostics Product Introduction
- 10.7.5 Clearbridge BioMedics Pte Ltd Recent Development
- 10.8 Epic Sciences Inc.
- 10.8.1 Epic Sciences Inc. Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Circulating Tumor Cell Diagnostics
- 10.8.4 Circulating Tumor Cell Diagnostics Product Introduction
- 10.8.5 Epic Sciences Inc. Recent Development
- 10.9 Fluxion Biosciences Inc.
- 10.9.1 Fluxion Biosciences Inc. Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Circulating Tumor Cell Diagnostics
- 10.9.4 Circulating Tumor Cell Diagnostics Product Introduction
- 10.9.5 Fluxion Biosciences Inc. Recent Development
- 10.10 ScreenCell
- 10.10.1 ScreenCell Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Circulating Tumor Cell Diagnostics
- 10.10.4 Circulating Tumor Cell Diagnostics Product Introduction
- 10.10.5 ScreenCell Recent Development
- 10.11 Silicon Biosystems
- 10.12 Sysmex Corporation
- 10.13 Greiner Bio-One GmbH
- 10.14 AdnaGen AG
- 10.15 Apocell Inc
- 10.16 Biocep Ltd
- 10.17 Canopus Bioscience Ltd
- 10.18 Creatv Microtech Inc
- 10.19 Ikonisys Inc
- 10.20 IV Diagnostics Inc
- 10.21 Miltenyi Biotech GmbH
- 10.22 Nanostring Technologies Inc
- 10.23 Rarecells Diagnostics.
- 10.24 Vitatex Inc
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Circulating Tumor Cell Diagnostics Sales Channels
- 11.2.2 Circulating Tumor Cell Diagnostics Distributors
- 11.3 Circulating Tumor Cell Diagnostics Customers
12 Market Forecast
- 12.1 Global Circulating Tumor Cell Diagnostics Sales and Revenue Forecast 2019-2025
- 12.2 Global Circulating Tumor Cell Diagnostics Sales Forecast by Type
- 12.3 Global Circulating Tumor Cell Diagnostics Sales Forecast by Application
- 12.4 Circulating Tumor Cell Diagnostics Forecast by Regions
- 12.4.1 Global Circulating Tumor Cell Diagnostics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Circulating Tumor Cell Diagnostics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Circulating Tumor Cell Diagnostics. Industry analysis & Market Report on Circulating Tumor Cell Diagnostics is a syndicated market report, published as Global (United States, European Union and China) Circulating Tumor Cell Diagnostics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Circulating Tumor Cell Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
